NEW YORK - A drug patent holder that settled patent infringement litigation by granting licenses to and entering requirements contracts with generic manufacturers does not violate federal antitrust law by breaching those requirements contracts, a federal judge in New York ruled March 6 (Louisiana Wholesale Drug Company, Inc. v. Shire LLC, et al., No. 12 Civ. 3711, S.D. N.Y.)....(read more)![]()
↧